In addition, cell counts of CD4+TIM-3+ and CD8+TIM-3+ TIL linearly correlated with tumor cell burden (figure 1A), indicating that progressing B16 melanoma tumors accumulate exhausted TIM-3+ TIL that fail to control tumor growth. The gene discussed is CD4; the disease is melanoma.